Huixing Wu

1.1k total citations
21 papers, 835 citations indexed

About

Huixing Wu is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Microbiology. According to data from OpenAlex, Huixing Wu has authored 21 papers receiving a total of 835 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 9 papers in Molecular Biology and 5 papers in Microbiology. Recurrent topics in Huixing Wu's work include Neonatal Respiratory Health Research (12 papers), Inhalation and Respiratory Drug Delivery (7 papers) and Influenza Virus Research Studies (3 papers). Huixing Wu is often cited by papers focused on Neonatal Respiratory Health Research (12 papers), Inhalation and Respiratory Drug Delivery (7 papers) and Influenza Virus Research Studies (3 papers). Huixing Wu collaborates with scholars based in United States, China and Poland. Huixing Wu's co-authors include Francis X. McCormack, Alexander I. Kuzmenko, Alison A. Weiss, James H. Fisher, Kwang Sik Kim, George S. Deepe, Reta S. Gibbons, Michael J. Rynkiewicz, Barbara A. Seaton and Marnie A. Ryan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Huixing Wu

20 papers receiving 816 citations

Peers

Huixing Wu
Barbara J. Zeligs United States
Neil Ritchie United Kingdom
Martin A. Bewley United Kingdom
Paul M. Loiselle United States
Anukul T. Shenoy United States
Riana Cockeran South Africa
Barbara J. Zeligs United States
Huixing Wu
Citations per year, relative to Huixing Wu Huixing Wu (= 1×) peers Barbara J. Zeligs

Countries citing papers authored by Huixing Wu

Since Specialization
Citations

This map shows the geographic impact of Huixing Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huixing Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huixing Wu more than expected).

Fields of papers citing papers by Huixing Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huixing Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huixing Wu. The network helps show where Huixing Wu may publish in the future.

Co-authorship network of co-authors of Huixing Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Huixing Wu. A scholar is included among the top collaborators of Huixing Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huixing Wu. Huixing Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Zhanxue, Dandan Su, Huixing Wu, et al.. (2025). PD-L1 antibody-modified plant-derived nanovesicles carrying a STING agonist for the combinational immunotherapy of melanoma. Biomaterials. 322. 123396–123396. 4 indexed citations
2.
Gibbons, Erin, Huixing Wu, Samia Lopa, et al.. (2024). Glycoprotein non-metastatic melanoma protein B promotes tumor growth and is a biomarker for lymphangioleiomyomatosis. Endocrine Related Cancer. 31(6). 6 indexed citations
3.
Gibbons, Erin, Huixing Wu, Samia Lopa, et al.. (2024). 7908 GPNMB Promotes Tumor Growth And Is A Biomarker For Lymphangioleiomyomatosis (LAM). Journal of the Endocrine Society. 8(Supplement_1).
4.
Xiang, Shijian, et al.. (2023). Isoliquiritigenin suppresses the progression of malignant melanoma via targeting H2A.Z.1-E2F1 pathway. Biochemical Pharmacology. 218. 115859–115859. 7 indexed citations
5.
Wu, Huixing, et al.. (2023). Isoliquiritigenin attenuates non-alcoholic fatty liver disease via the amelioration of hepatic inflammation and autophagy in mice. Journal of Functional Foods. 109. 105770–105770. 7 indexed citations
6.
Wang, Zonggui, Yanfang Zhou, Zhong Dai, et al.. (2021). A Novel Long Noncoding RNA, Lnc‐OAD, Is Required for Bone Morphogenetic Protein 2‐ (BMP‐2‐) Induced Osteoblast Differentiation. BioMed Research International. 2021(1). 6697749–6697749. 5 indexed citations
7.
Nikolaidis, Nikolaos M., John G. Noel, Huixing Wu, et al.. (2017). Mitogenic stimulation accelerates influenza-induced mortality by increasing susceptibility of alveolar type II cells to infection. Proceedings of the National Academy of Sciences. 114(32). E6613–E6622. 30 indexed citations
8.
Rynkiewicz, Michael J., Huixing Wu, Nikolaos M. Nikolaidis, et al.. (2017). Differential Ligand Binding Specificities of the Pulmonary Collectins Are Determined by the Conformational Freedom of a Surface Loop. Biochemistry. 56(31). 4095–4105. 8 indexed citations
9.
Wu, Huixing, et al.. (2016). Keratinocyte growth factor supports pulmonary innate immune defense through maintenance of alveolar antimicrobial protein levels and macrophage function. American Journal of Physiology-Lung Cellular and Molecular Physiology. 310(9). L868–L879. 22 indexed citations
10.
Goh, Boon Chong, Huixing Wu, Michael J. Rynkiewicz, et al.. (2016). Elucidation of Lipid Binding Sites on Lung Surfactant Protein A Using X-ray Crystallography, Mutagenesis, and Molecular Dynamics Simulations. Biochemistry. 55(26). 3692–3701. 27 indexed citations
11.
Wu, Huixing, Takuji Suzuki, Brenna Carey, Bruce C. Trapnell, & Francis X. McCormack. (2011). Keratinocyte Growth Factor Augments Pulmonary Innate Immunity through Epithelium-driven, GM-CSF-dependent Paracrine Activation of Alveolar Macrophages. Journal of Biological Chemistry. 286(17). 14932–14940. 22 indexed citations
12.
Rynkiewicz, Michael J., et al.. (2010). Crystallographic Complexes of Surfactant Protein A and Carbohydrates Reveal Ligand-induced Conformational Change. Journal of Biological Chemistry. 286(1). 757–765. 22 indexed citations
13.
Ryan, Marnie A., Henry T. Akinbi, Alicia G. Serrano, et al.. (2006). Antimicrobial Activity of Native and Synthetic Surfactant Protein B Peptides. The Journal of Immunology. 176(1). 416–425. 58 indexed citations
14.
Kuzmenko, Alexander I., Huixing Wu, & Francis X. McCormack. (2006). Pulmonary Collectins Selectively Permeabilize Model Bacterial Membranes Containing Rough Lipopolysaccharide. Biochemistry. 45(8). 2679–2685. 25 indexed citations
15.
Kuzmenko, Alexander I., et al.. (2005). Surfactant Protein A Is a Principal and Oxidation-sensitive MicrobialPermeabilizing Factor in the Alveolar LiningFluid. Journal of Biological Chemistry. 280(27). 25913–25919. 24 indexed citations
16.
McCormack, Francis X., et al.. (2004). Bordetella pertussis Lipopolysaccharide Resists the Bactericidal Effects of Pulmonary Surfactant Protein A. The Journal of Immunology. 173(3). 1959–1965. 44 indexed citations
18.
McCormack, Francis X., et al.. (2003). Macrophage-independent Fungicidal Action of the Pulmonary Collectins. Journal of Biological Chemistry. 278(38). 36250–36256. 105 indexed citations
19.
Wu, Huixing, Alexander I. Kuzmenko, Alison A. Weiss, et al.. (2003). Surfactant proteins A and D inhibit the growth of Gram-negative bacteria by increasing membrane permeability. Journal of Clinical Investigation. 111(10). 1589–1602. 326 indexed citations
20.
Palaniyar, Nades, Alexander I. Kuzmenko, Machiko Ikegami, et al.. (2002). The Role of Pulmonary Collectin N-terminal Domains in Surfactant Structure, Function, and Homeostasis in Vivo. Journal of Biological Chemistry. 277(30). 26971–26979. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026